scholarly journals Nerve growth factor treatment or cAMP elevation reduces Ca2+/calmodulin-dependent protein kinase III activity in PC12 cells.

1987 ◽  
Vol 262 (29) ◽  
pp. 14265-14272 ◽  
Author(s):  
A C Nairn ◽  
R A Nichols ◽  
M J Brady ◽  
H C Palfrey
Neuron ◽  
1990 ◽  
Vol 4 (3) ◽  
pp. 355-366 ◽  
Author(s):  
Daniel Kalman ◽  
Bradley Wong ◽  
Andrew E. Horvai ◽  
Martin J. Cline ◽  
Paul H. O'Lague

1986 ◽  
Vol 103 (3) ◽  
pp. 887-893 ◽  
Author(s):  
J Cremins ◽  
J A Wagner ◽  
S Halegoua

Nerve growth factor (NGF) mediates the phosphorylation of tyrosine hydroxylase in PC12 cells on two distinct peptide fragments, separable by two-dimensional tryptic phosphopeptide mapping (phosphopeptides T1 and T3). Phorbol diester derivatives capable of activating Ca+2/phospholipid-dependent protein kinase (C-kinase) cause a specific phosphorylation of peptide T3 in a dose-dependent, saturable manner. Derivatives of the endogenous C-kinase activator diacylglycerol, also cause the phosphorylation of tyrosine hydroxylase on peptide T3. The C-kinase inhibitors chlorpromazine and trifluoperazine inhibit the phorbol diester stimulated phosphorylation of site T3 in a dose-dependent manner. These agents inhibit the phosphorylation of T3 in response to NGF, but have no effect on NGF's ability to cause T1 phosphorylation. In a PC12 mutant deficient in cAMP-dependent protein kinase activity, NGF mediates the phosphorylation of tyrosine hydroxylase on peptide T3 but not on T1. We conclude that NGF mediates the activation of both the cAMP-dependent protein kinase and the C-kinase to phosphorylate substrate proteins. These kinases can act independently to phosphorylate tyrosine hydroxylase, each at a different site, and each of which results in the enzyme activation. A molecular framework is thus provided for events underlying NGF action.


Sign in / Sign up

Export Citation Format

Share Document